Review of batch manufacturing records including raw material inspection, in process & finished product inspection does not reveal any discrepancy relevant to the batch under investigation, which confirms that there is no indication of a product related quality deficiency associated to this batch.Control sample test results confirm that there was no indication of a product quality deficiency in the batch under investigation.Without the return of the device for analysis, the reported customer complaint could not be confirmed and no determination of possible contributing factors could be made.Based on the available information and without the concomitant device, it is not possible to draw a clinical conclusion between the device and the reported event.Review of the complaint history identified no other incidents reported from this lot.Considering all above and as the clinical situations cannot be duplicated in our analysis lab, a conclusive cause for the reported incident, and the relationship to the product, if any, cannot be determined.Neither the dhr review nor the control sample analysis including complaint history review suggests that the reported failures could be related to the design or the manufacturing process.Note: this complaint is received from outside the usa.No units from this batch has been distributed in the usa.However, it is being reported to the fda as this product is cleared in the usa.(b)(4).
|
As reported, 3.00 x 15mm mozec(tm) nc rx ptca balloon dilatation catheter, batch #: mnco52 was used in a pci.While withdrawing, it was very difficult to retrieve without taking the guide wire.This increase the radiation time.
|